C07D 337/06
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D337/06 (Condensed with carbocyclic rings or ring systems) appears on 196 US grants and 91 published applications in this corpus.
Search patents in C07D- Granted patents
- 196
- Published applications
- 91
- Assignees
- 81
- Inventors
- 439
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 14 | 0 |
| 1978 | 7 | 0 |
| 1979 | 6 | 0 |
| 1980 | 11 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 4 | 0 |
| 1984 | 4 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 7 | 0 |
| 1988 | 7 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 7 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 12 | 4 |
| 2002 | 12 | 6 |
| 2003 | 8 | 9 |
| 2004 | 5 | 12 |
| 2005 | 5 | 5 |
| 2006 | 1 | 4 |
| 2007 | 2 | 3 |
| 2008 | 3 | 0 |
| 2009 | 0 | 5 |
| 2010 | 1 | 3 |
| 2011 | 4 | 3 |
| 2012 | 0 | 1 |
| 2013 | 1 | 4 |
| 2014 | 1 | 4 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 3 |
| 2020 | 0 | 3 |
| 2021 | 1 | 1 |
| 2022 | 3 | 3 |
| 2023 | 2 | 1 |
| 2024 | 1 | 6 |
| 2025 | 4 | 3 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Urolithin derivatives and methods of use thereof18 Nov 2025US 12,473,269 B2Vandria SA
- Urolithin derivatives and methods of use thereof15 Jul 2025US 12,358,884 B2Vandria SA
- Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases8 Jul 2025US 12,350,267 B2Shire Human Genetic Therapies, Inc.
- Urolithin derivatives and methods of use thereof8 Jul 2025US 12,351,567 B2Vandria SA
- Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease19 Nov 2024US 12,145,959 B2Shire Human Genetic Therapies, Inc.
- Processes of producing volixibat and analogs thereof24 Sep 2026US 2026/0285895 A1Mirum Pharmaceuticals, Inc.
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Urolithin derivatives and methods of use thereof14 May 2026US 2026/0132117 A1Vandria SA
- Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases11 Sep 2025US 2025/0281482 A1Shire Human Genetic Therapies, Inc.
- Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease11 Sep 2025US 2025/0282808 A1Shire Human Genetic Therapies, Inc.
Most cited
By later US patents
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake111US 5,994,391 AG. D. Searle & Co. · 1999
- Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake77US 6,387,924 B2G. D. Searle & Co. · 2002
- Benzothiepine ileal bile acid transport inhibitors75US 7,226,943 B2AstraZeneca AB · 2007
- Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors72US 6,943,189 B2G. D. Searle & Co. · 2005